# Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer

> **NCT02479945** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 6 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** Obtaining biospecimen

## Key facts

- **NCT ID:** NCT02479945
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-04-25
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02479945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02479945, "Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02479945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*